Want to see CVSI full AI Analyst Report?
Total Valuation
CV Sciences has a market cap or net worth of $4.90M. The enterprise value is $4.85M.
Market Cap$4.90M
Enterprise Value$4.85M
Share Statistics
CV Sciences has 203,977,520 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding203,977,520
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CV Sciences’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -28.58%.
Return on Equity (ROE)-0.65
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-28.58%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee293.38K
Profits Per Employee-20.38K
Employee Count47
Asset Turnover1.98
Inventory Turnover1.72
Valuation Ratios
The current PE Ratio of CV Sciences is ―. CV Sciences’s PEG ratio is 0.19.
PE Ratio―
PS Ratio0.82
PB Ratio7.71
Price to Fair Value7.71
Price to FCF-21.93
Price to Operating Cash Flow-19.94
PEG Ratio0.19
Income Statement
In the last 12 months, CV Sciences had revenue of 13.79M and earned -958.00K in profits. Earnings per share was >-0.01.
Revenue13.79M
Gross Profit6.75M
Operating Income-992.00K
Pretax Income-949.00K
Net Income-958.00K
EBITDA-562.00K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -225.00K and capital expenditures -72.00K, giving a free cash flow of -297.00K billion.
Operating Cash Flow-225.00K
Free Cash Flow-297.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
CV Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.33
52-Week Price Change-38.46%
50-Day Moving Average0.03
200-Day Moving Average0.04
Relative Strength Index (RSI)8.95
Average Volume (3m)246.65K
Important Dates
CV Sciences upcoming earnings date is Aug 17, 2026, TBA (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 17, 2026
Ex-Dividend Date―
Financial Position
CV Sciences as a current ratio of 1.03, with Debt / Equity ratio of 99.47%
Current Ratio1.03
Quick Ratio0.21
Debt to Market Cap0.17
Net Debt to EBITDA-2.37
Interest Coverage Ratio-1.92
Taxes
In the past 12 months, CV Sciences has paid 9.00K in taxes.
Income Tax9.00K
Effective Tax Rate>-0.01
Enterprise Valuation
CV Sciences EV to EBITDA ratio is -22.50, with an EV/FCF ratio of -24.51.
EV to Sales0.92
EV to EBITDA-22.50
EV to Free Cash Flow-24.51
EV to Operating Cash Flow-31.07
Balance Sheet
CV Sciences has $309.00K in cash and marketable securities with $1.49M in debt, giving a net cash position of -$1.18M billion.
Cash & Marketable Securities$309.00K
Total Debt$1.49M
Net Cash-$1.18M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 49.75%, with operating margin of -7.19%, and net profit margin of -6.95%.
Gross Margin49.75%
Operating Margin-7.19%
Pretax Margin-6.88%
Net Profit Margin-6.95%
EBITDA Margin-4.08%
EBIT Margin-7.19%
Analyst Forecast
The average price target for CV Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-12.61%
EPS Growth Forecast23.08%